The Pharma Data

DECEMBER 3, 2020

The Phase 1 trial was a randomized, observer-blind, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of the adjuvanted COVID-19 S-Trimer vaccine candidates formulated with different antigen levels. About Trimer-Tag © Technology. About COVID-19 S-Trimer Vaccine. About Clover Biopharmaceuticals.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

Intouch Solutions

APRIL 11, 2024

It has continually evolved, embracing new technologies and methodologies to improve drug discovery, development, and distribution. but others must be external such as: electronic health records, prescription data, medical literature, social media, and more. This can make a difference in all cases, but particularly with rare diseases.

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

XTalks

FEBRUARY 27, 2024

Technologies like CRISPR-Cas9 have revolutionized the potential for gene editing, offering hope for curative treatments for conditions like Duchenne muscular dystrophy (DMD) and certain types of inherited blindness. Sarepta hopes to clarify Elvidys’ effectiveness in older children in a confirmatory trial.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

Pharmaceutical Technology

JANUARY 27, 2023

Dr. James George, a research professor at the University of Oklahoma Health Sciences Center, said Cablivi “adds a new aspect to treatment, the prompt recovery of platelets and prompt resolution of transient neurologic symptoms”. GlobalData is the parent company of Pharmaceutical Technology. cases per million in Europe.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130

Pharmaceutical Technology

OCTOBER 10, 2022

Using sophisticated assignment rules and virtual tagging, each line item inside the unified bill can be assigned to its business role, feature, team, and product. The leadership team can use FinOps dashboards to track consumption and gross margin, assess unit cost over time, and then distribute it to clients.

Production 130

Production Engineer Development Marketing 130

Rethinking Clinical Trials

MARCH 21, 2023

Quality of life (QOL) was assessed at 6 months. In the PRO arm there was a statistically significant improved physical function score, the study found significant benefits for the PRO arm for symptoms, and significant benefits on health-related quality of life. months longer among patients in the self-reporting arm.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

XTalks

DECEMBER 21, 2022

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. Virtual trial processes involve the use of technologies that enable remote data collection and sharing.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

Drug Discovery World

NOVEMBER 9, 2023

Ahead of protein and antibody engineering conference PEGS Europe 2024 in Lisbon, DDW’s Megan Thomas looks at what to expect from each track of the annual biologics technology meeting. Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’.

Engineer 52

Engineer Antibody Protein In-Vivo 52

The Pharma Data

MAY 4, 2021

down 21%, driven by a negative impact from the COVID-19 pandemic resulting in a decline in patient visits to doctors for preventative health purposes, as well as the loss of patent protection in the U.S. The study was designed to assess the safety and efficacy of continued treatment with relugolix combination therapy for up to two years.

Vaccination 40

Vaccination Vaccine Production Sales 40